-
-
-
-
-
-
-
Pfizer (PFE), BioNTech (BNTX) Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
-
-
-
-
-
-
-
Health Canada authorizes Pfizer (PFE) -BioNTech (BNTX) COVID-19 vaccine for children six months to four years of age
-
-
-
-
-
-
-
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
-
-
-
-
-
-
-
Novavax's COVID-19 Vaccine Wins FDA AdCom Blessing, Removing 'Major Overhang'
-
-
-
-
-
-
-
FDA Expands Eligibility for Pfizer (PFE) -BioNTech (BNTX) COVID-19 Booster Dose to 16- and 17-Year-Olds
-
-
-
-
-
-
-
Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
-
-
-
-
-
-
-
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
-
15,404 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

